The rat ErbB 2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB 2 + mammary cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

  2014cited by this paper
• The use of transient expression systems for the rapid production of virus-like particles in plants.

  2013cited by this paper
• Breakthrough of the year 2013. Cancer immunotherapy.

  2013cited by this paper
• Targeted Therapy for Breast Cancer Prevention

  2013cited by this paper
• Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization.

  2013cited by this paper
• In silico Platform for Prediction of N-, O- and C-Glycosites in Eukaryotic Protein Sequences

  2013cited by this paper
• Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants

  2011cited by this paper
• Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

  2011cited by this paper
• A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions

  2011cited by this paper
• A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.

  2010cited by this paper
• Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation

  2010cited by this paper
• Plant‐made vaccines for humans and animals

  2010cited by this paper
• The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity

  2009cited by this paper
• pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants.

  2009cited by this paper
• Immunogenicity of Allo-Vesicle Carrying ERBB2 Tumor Antigen for Dendritic Cell-Based Anti-Tumor Immunotherapy

  2009cited by this paper
• ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas.

  2008cited by this paper
• DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma

  2008cited by this paper
• Anchorage to the cytosolic face of the endoplasmic reticulum membrane: a new strategy to stabilize a cytosolic recombinant antigen in plants.

  2008cited by this paper
• Expression and Purification of Pharmaceutical Proteins in Plants

  2008cited by this paper
• Extremely High-Level and Rapid Transient Protein Production in Plants without the Use of Viral Replication1

  2008cited by this paper
• Approaches to achieve high-level heterologous protein production in plants.

  2007cited by this paper
• Vaccines for tumour prevention

  2006cited by this paper
• Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.

  2006cited by this paper
• Systemic Agrobacterium tumefaciens–mediated transfection of viral replicons for efficient transient expression in plants

  2005cited by this paper
• Antibody processing and engineering in plants, and new strategies for vaccine production.

  2005cited by this paper
• Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

  2004cited by this paper
• Agrobacterium-Mediated Plant Transformation: the Biology behind the “Gene-Jockeying” Tool

  2003cited by this paper
• pGD vectors: versatile tools for the expression of green and red fluorescent protein fusions in agroinfiltrated plant leaves.

  2002cited by this paper
• HER2/Neu: mechanisms of dimerization/oligomerization

  2000cited by this paper
• A plant‐derived edible vaccine against hepatitis B virus

  1999cited by this paper
• Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

  1998cited by this paper
• Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

  1998cited by this paper
• An Agrobacterium-mediated transient gene expression system for intact leaves

  1997cited by this paper
• Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival

  1995cited by this paper
• An immunohistologic evaluation of C‐erbB‐2 gene product in patients with urinary bladder carcinoma

  1992cited by this paper
• p185neu expression in human lung adenocarcinomas predicts shortened survival.

  1990cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Extraction of proteins for sodium dodecyl sulfate-polyacrylamide gel electrophoresis from protease-rich plant tissues.

  1984cited by this paper

• Reconceptualizing cancer immunotherapy based on plant production systems

  2017cites this paper